{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:09:15Z","timestamp":1792724955342,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100022241","name":"Office of Research, Innovation and Commercialization, University of Agriculture Faisalabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109364","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:11:28Z","timestamp":1765296688000},"page":"109364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["A series of 4-thiomorpholinophenyl-thiosemicarbazones as cholinesterase inhibitors with anti-neuroblastoma effects"],"prefix":"10.1016","volume":"168","author":[{"given":"Hina","family":"Aftab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furkan","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurbet \u00c7elik","family":"Turgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastaran","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima D.","family":"Alharthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaattin","family":"\u015een","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi E.A.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobhi M.","family":"Gomha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halil","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109364_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101503","article-title":"A promising acetylcholinesterase and butyrylcholinesterase inhibitors: in vitro enzymatic and in silico molecular docking studies of benzothiazole-based oxadiazole containing imidazopyridine hybrid derivatives","volume":"7","author":"Hussain","year":"2024","journal-title":"Results Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0010","article-title":"Expression profiles of long noncoding RNAs in intranasal LPS-mediated Alzheimer's disease model in mice","volume":"2019","author":"Tang","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bioorg.2025.109364_bb0015","doi-asserted-by":"crossref","DOI":"10.4103\/NRR.NRR-D-25-00274","article-title":"Neurodegenerative diseases and immune system: from pathogenic mechanism to therapy","author":"Chen","year":"2025","journal-title":"Neural Regen. Res."},{"issue":"10043","key":"10.1016\/j.bioorg.2025.109364_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.109364_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40035-018-0107-y","article-title":"Alzheimer's disease hypothesis and related therapies","volume":"7","author":"Du","year":"2018","journal-title":"Transl. Neurodegen."},{"key":"10.1016\/j.bioorg.2025.109364_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fneur.2017.00102","article-title":"Alzheimer's disease: biomarkers in the genome, blood, and cerebrospinal fluid","volume":"8","author":"Huynh","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bioorg.2025.109364_bb0035","article-title":"Discovery of novel thiosemicarbazone-acridine targeting butyrylcholinesterase with antioxidant, metal complexing and neuroprotector abilities as potential treatment of Alzheimer's disease: in vitro, in vivo, and in silico studies","volume":"281","author":"Sousa","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109364_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2025.1524292","article-title":"Effects of an interdisciplinary programme on psychoemotional factors in informal caregivers of people with Alzheimer's disease","volume":"16","author":"Mu\u00f1oz-Bermejo","year":"2025","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109364_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70088","article-title":"Sulfonamide-bearing pyrazolone derivatives as multitarget therapeutic agents: design, synthesis, characterization, biological evaluation, in silico ADME\/T profiling and molecular docking study","volume":"13","author":"Lolak","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109364_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400909","article-title":"Anticholinesterase and carbonic anhydrase inhibitory activities of natural carnosic acid derivatives: a comprehensive in vitro and in silico study","volume":"358","author":"K\u00f6ksal","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109364_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110450","article-title":"Design, synthesis, and biological studies of isoniazid-based hydrazone derivatives: antibacterial, anticancer, and enzyme inhibitory properties","volume":"770","author":"Kalay","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2025.109364_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136582","article-title":"Molecular modeling, synthesis, and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory activities of novel benzimidazole-bearing thiadiazole derivatives","volume":"1295","author":"Hussain","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109364_bb0065","article-title":"Natural acetylcholinesterase inhibitors: a multi-targeted therapeutic potential in Alzheimer's disease","volume":"11","author":"Gajendra","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109364_bb0070","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00044-023-03031-z","article-title":"Synthesis of nitrogen-containing oleanolic acid derivatives as carbonic anhydrase and acetylcholinesterase inhibitors","volume":"32","author":"\u015eenol","year":"2023","journal-title":"Med. Chem. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109364_bb0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1567205017666200424133534","article-title":"Anticholinesterase and antioxidant activities of natural Abietane Diterpenoids with molecular docking studies","volume":"17","author":"Topcu","year":"2020","journal-title":"Curr. Alzheimer Res."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109364_bb0080","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s13738-023-02861-3","article-title":"Synthesis of new carboxylates and sulfonates containing thiazolidin-4-one ring and evaluation of inhibitory properties against some metabolic enzymes","volume":"20","author":"Tokal\u0131","year":"2023","journal-title":"J. Iran. Chem. Soc."},{"issue":"25","key":"10.1016\/j.bioorg.2025.109364_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202301158","article-title":"Synthesis and evaluation of Quinazolin-4(3)-one derivatives as multitarget metabolic enzyme inhibitors: a biochemistry-oriented drug design","volume":"8","author":"Tokal\u0131","year":"2023","journal-title":"ChemistrySelect"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109364_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202204191","article-title":"Carboxylate- and sulfonate-containing quinazolin-4(3H)-one rings: synthesis, characterization, and carbonic anhydrase I\u2013II and acetylcholinesterase inhibition properties","volume":"8","author":"Tokal\u0131","year":"2023","journal-title":"ChemistrySelect"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109364_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000455","article-title":"Design, synthesis, molecular docking, and some metabolic enzyme inhibition properties of novel quinazolinone derivatives","volume":"354","author":"Tokali","year":"2021","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"20","key":"10.1016\/j.bioorg.2025.109364_bb0100","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.3390\/molecules28207015","article-title":"Design, synthesis, in vitro biological evaluation and in silico molecular docking study of Benzimidazole-based oxazole analogues: a promising acetylcholinesterase and Butyrylcholinesterase inhibitors","volume":"28","author":"Hussain","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109364_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.340949","article-title":"Cytotoxicity, uptake and accumulation of selenium nanoparticles and other selenium species in neuroblastoma cell lines related to Alzheimer's disease by using cytotoxicity assays, TEM and single cell-ICP-MS","volume":"1249","author":"Vicente-Zurdo","year":"2023","journal-title":"Anal. Chim. Acta"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109364_bb0110","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/ph16091198","article-title":"Synthesis, DFT study, and in vitro evaluation of antioxidant properties and cytotoxic and Cytoprotective effects of new Hydrazones on SH-SY5Y neuroblastoma cell lines","volume":"16","author":"Tzankova","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0115","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11033-025-10633-w","article-title":"Advancements in neuroblastoma treatment: FDA-approved drugs and role of phytochemicals","volume":"52","author":"Rajpoot","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0120","doi-asserted-by":"crossref","first-page":"s323","DOI":"10.5530\/ijper.20256349","article-title":"Synthesis and evaluation of 2, 5-substituted Pyrazolone for neuroprotective potential in SH-SY5Y human neuroblastoma cells","volume":"59","author":"Manikandan","year":"2025","journal-title":"Indian J. Pharma. Edu. Res."},{"key":"10.1016\/j.bioorg.2025.109364_bb0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuro.2022.07.008","article-title":"The SH-SY5Y human neuroblastoma cell line, a relevant in vitro cell model for investigating neurotoxicology in human: focus on organic pollutants","volume":"92","author":"Lopez-Suarez","year":"2022","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0130","first-page":"297","article-title":"Neuroblastoma","volume":"58","author":"Colon","year":"2011","journal-title":"Adv. Pediatr. Infect. Dis."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109364_bb0135","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3390\/biom15081188","article-title":"Apelin-13-mediated upregulation of METTL3 ameliorates Alzheimer's disease via inhibiting Neuroinflammation through m6A-dependent regulation of lncRNA BDNF-AS","volume":"15","author":"Han","year":"2025","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109364_bb0140","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3923\/ijp.2023.881.892","article-title":"Autophagy anticancer properties of Rosmarinus officinalis L. essential oils on the SH-SY5Y neuroblastoma cell line in vitro","volume":"19","author":"Al-Dbass","year":"2023","journal-title":"IJP"},{"key":"10.1016\/j.bioorg.2025.109364_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109252","article-title":"Dual targeting of neuroblastoma and cholinesterase by morpholino\/pyrrolidino-sulfonyl-indole thiosemicarbazones: synthesis, characterization, enzyme inhibition, cytotoxicity, docking and dynamics studies","volume":"167","author":"Batool","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"36","key":"10.1016\/j.bioorg.2025.109364_bb0150","doi-asserted-by":"crossref","first-page":"29960","DOI":"10.1039\/D5RA03877D","article-title":"New 1E,1\u2032E-hydrazine-bis(phenoxy-1,2,3-triazol-acetamide) derivatives as potent inhibitors against acetylcholinesterase, butyrylcholinesterase, and \u03b1-glucosidase","volume":"15","author":"Kermaninia","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109364_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108869","article-title":"Novel thiazolidinedione hybrids as cholinesterase inhibitors and targeting neuroblastoma: design, synthesis, in vitro and in silico biological evaluations","volume":"164","author":"Turgut","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109364_bb0160","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.17732","article-title":"Secretomic changes of amyloid beta peptides on Alzheimer's disease related proteins in differentiated human SH-SY5Y neuroblastoma cells","volume":"12","author":"Roytrakul","year":"2024","journal-title":"Peerj"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109364_bb0165","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/00207454.2020.1754211","article-title":"In vitro neuroprotective effects of farnesene sesquiterpene on alzheimer's disease model of differentiated neuroblastoma cell line","volume":"131","author":"Arslan","year":"2021","journal-title":"Int. J. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0170","doi-asserted-by":"crossref","first-page":"22645","DOI":"10.1038\/s41598-024-72858-2","article-title":"Design, synthesis, in vitro and in silico studies of novel piperidine derived thiosemicarbazones as inhibitors of dihydrofolate reductase","volume":"14","author":"Aftab","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109364_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108118","article-title":"Synthesis, biological evaluation, and in silico studies of phenyl naphthalene-2-sulfonate derived thiosemicarbazones as potential carbonic anhydrase inhibitors","volume":"155","author":"Eshal","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109364_bb0180","doi-asserted-by":"crossref","first-page":"118301","DOI":"10.1016\/j.bmc.2025.118301","article-title":"Synthesis of 6-ethoxyphenyl 4-fluorobenzenesulfonate-tagged thiosemicarbazones as carbonic anhydrase inhibitors: in-vitro and in silico approach","volume":"129","author":"Munir","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109364_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108717","article-title":"N-hexylsulfonyl indole based thiosemicarbazones as potent and selective ecto-5\u2032-nucleotidase and NTPDase inhibitors","volume":"163","author":"Batool","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109364_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108155","article-title":"Design, synthesis, in-vitro and in-silico studies of novel N-heterocycle based hydrazones as \u03b1-glucosidase inhibitors","volume":"156","author":"Farooqi","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"43","key":"10.1016\/j.bioorg.2025.109364_bb0195","doi-asserted-by":"crossref","first-page":"31409","DOI":"10.1039\/D4RA05071A","article-title":"Synthesis, in vitro biological evaluation and in silico studies of novel pyrrolidine derived thiosemicarbazones as dihydrofolate reductase inhibitors","volume":"14","author":"Aftab","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109364_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142141","article-title":"Synthetic strategies, biological and computational screening of thiadiazole bearing benzothiazole derivatives as prospective anti-diabetic agents","volume":"1337","author":"Hussain","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109364_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101823","article-title":"Investigation of novel bis-thiadiazole bearing schiff base derivatives as effective inhibitors of thymidine phosphorylase: Synthesis, in vitro bioactivity and molecular docking study","volume":"31","author":"Hussain","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioorg.2025.109364_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140197","article-title":"Synthesis and biological studies of acetophenone-based novel chalcone, semicarbazone, thiosemicarbazone and indolone derivatives: structure-activity relationship, molecular docking, molecular dynamics, and kinetic studies","volume":"1321","author":"Farzaliyeva","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109364_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/aoc.7620","article-title":"Thiosemicarbazones and derived tin complexes: synthesis, structural analysis and in vitro evaluation against bacterial and cancer cells","volume":"38","author":"Ibrahim","year":"2024","journal-title":"Appl. Organomet. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0220","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/biology13010060","article-title":"DNA interactions and biological activity of 2,9-Disubstituted 1,10-Phenanthroline Thiosemicarbazone-based ligands and a 4-Phenylthiazole derivative","volume":"13","author":"Nicol\u00e1s","year":"2024","journal-title":"Biology-Basel"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109364_bb0225","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/jhet.4619","article-title":"Novel thiosemicarbazone and thiazolidin-4-one derivatives containing vanillin core: synthesis, characterization, and anticancer activity studies","volume":"60","author":"Tokal\u0131","year":"2023","journal-title":"J. Heterocyclic Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109364_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300370","article-title":"Synthesis, characterization, biochemical, and molecular modeling studies of carvacrol-based new thiosemicarbazide and 1,3,4-thiadiazole derivatives","volume":"356","author":"Alagoz","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/molecules28010021","article-title":"Synthesis of new Triazole-based Thiosemicarbazone derivatives as anti-Alzheimer's disease candidates: evidence-based in vitro study","volume":"28","author":"Rahim","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109364_bb0240","article-title":"Advances in breast Cancer drug discovery: a review of therapeutic strategies and studies involving photosensitizers, caged Xanthones and Thiosemicarbazones derivatives","author":"Oliveira","year":"2023","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.109364_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129666","article-title":"Synthesis, characterization, biological activity and molecular docking studies of novel schiff bases derived from thiosemicarbazide: biochemical and computational approach","volume":"1231","author":"Tokal\u0131","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109364_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.05.026","article-title":"Synthetic transformation of 6-Fluoroimidazo[1,2-a]Pyridine-3-carbaldehyde into 6-Fluoroimidazo[1,2-a]pyridine-oxazole derivatives: in vitro urease inhibition and in silico study","volume":"31","author":"Hussain","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioorg.2025.109364_bb0255","doi-asserted-by":"crossref","DOI":"10.1080\/17568919.2025.2515812","article-title":"Therapeutic potential of morpholine-based compounds in neurodegenerative diseases: SAR insights and analysis","author":"Kumar","year":"2025","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23554","article-title":"New palladium complexes with N-heterocyclic carbene and morpholine ligands: synthesis, characterization, crystal structure, molecular docking, and biological activities","volume":"38","author":"Behcet","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0265","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14599","article-title":"A series of quinazolin-4(3H)-one-morpholine hybrids as anti-lung-cancer agents: synthesis, molecular docking, molecular dynamics, ADME prediction and biological activity studies","volume":"104","author":"Tokal\u0131","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109364_bb0270","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.3390\/molecules29133043","article-title":"Morpholine, Piperazine, and Piperidine derivatives as antidiabetic agents","volume":"29","author":"Zolotareva","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109364_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103578","article-title":"Morpholine as ubiquitous pharmacophore in medicinal chemistry: deep insight into the structure-activity relationship (SAR)","volume":"96","author":"Kumari","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109364_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101698","article-title":"Pyrazine based novel molecules as potential therapeutic agents: synthesis, in vitro biological screening, in silico ADMET profiling and molecular docking study","volume":"10","author":"Hussain","year":"2024","journal-title":"Results Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109364_bb0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.55971\/EJLS.1497639","article-title":"Investigation of dual AChE\/MAO inhibitory activities of new morpholine and piperazine structured compounds","volume":"3","author":"Kurban","year":"2024","journal-title":"Eur. J. Life Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109364_bb0290","doi-asserted-by":"crossref","first-page":"795","DOI":"10.6023\/cjoc201509002","article-title":"Synthesis, characterization and anticancer activity of Oleanolic acid and Ursolic acid derivatives","volume":"36","author":"Chen","year":"2016","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.109364_bb0295","series-title":"Synthesis, Characterization and Antimicrobial Evaluation of Novel 2-Pyrazoline Derivatives Containing Morpholine Moiety","author":"Kr","year":"2017"},{"key":"10.1016\/j.bioorg.2025.109364_bb0300","first-page":"1","article-title":"Synthesis of isatin-schiff base and 1, 2, 3-Triazole hybrids as anti-SARS-CoV-2 agents: DFT, molecular docking, and ADMET studies","author":"El Malah","year":"2025","journal-title":"Polycycl. Aromat. Compd."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0305","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11030-024-10859-z","article-title":"Development of novel 9 H-carbazole-4 H-chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"29","author":"Sharon","year":"2025","journal-title":"Mol. Divers."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109364_bb0310","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201900144","article-title":"Design, synthesis, and cholinesterase inhibition assay of coumarin-3-carboxamide-N-morpholine hybrids as new anti-alzheimer agents","volume":"16","author":"Tehrani","year":"2019","journal-title":"Chem. Biodivers."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109364_bb0315","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1016\/j.bmc.2008.03.019","article-title":"Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer's dementia models","volume":"16","author":"Kumar","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109364_bb0320","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/14756366.2020.1842390","article-title":"Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations","volume":"36","author":"Sasidharan","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109364_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104554","article-title":"Probing 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones as multi-target directed ligands against cholinesterases, carbonic anhydrases and \u03b1-glycosidase enzymes","volume":"107","author":"Hashmi","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109364_bb0330","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202301063","article-title":"Synthesis, theoretical, in silico and in vitro biological evaluation studies of new thiosemicarbazones as enzyme inhibitors","volume":"20","author":"Erdo\u011fan","year":"2023","journal-title":"Chem. Biodivers."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109364_bb0335","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1080\/07391102.2020.1782266","article-title":"Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease","volume":"39","author":"Mathew","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.109364_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137841","article-title":"Pristine 2-chloroquinoline-based-thiosemicarbazones as multitarget agents against alzheimer's disease: in vitro and in silico studies of monoamine oxidase (MAO) and cholinesterase (ChE) inhibitors","volume":"1306","author":"Jalil","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109364_bb0345","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2174\/1570180819666211230123145","article-title":"Identification of potential inhibitors for severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) angiotensin-converting enzyme 2 and the Main protease from Anatolian traditional plants","volume":"19","author":"K\u0131l\u0131n\u00e7","year":"2022","journal-title":"Lett. Drug. Des. Discov."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109364_bb0350","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bmc.2016.11.015","article-title":"Computer design, synthesis, and bioactivity analyses of drugs like fingolimod used in the treatment of multiple sclerosis","volume":"25","author":"Turgut","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109364_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202301134","article-title":"Novel Quinazolinone derivatives: potential synthetic analogs for the treatment of Glaucoma, Alzheimer's disease and diabetes mellitus","volume":"20","author":"Tokali","year":"2023","journal-title":"Chem. Biodivers."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109364_bb0360","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1080\/07391102.2020.1790422","article-title":"Benzenesulfonamide derivatives as potent acetylcholinesterase, \u03b1-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies","volume":"39","author":"Taslimi","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109364_bb0365","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21973","article-title":"Synephrine and phenylephrine act as alpha-amylase, alpha-glycosidase, acetylcholinesterase, butyrylcholinesterase, and carbonic anhydrase enzymes inhibitors","volume":"31","author":"Taslimi","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2025.109364_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.125006","article-title":"New tetrahydro-isoquinoline derivatives as cholinesterase and \u03b1-glycosidase inhibitors: synthesis, characterization, molecular docking & dynamics, ADME prediction, in vitro cytotoxicity and enzyme inhibition studies","volume":"404","author":"Mamedov","year":"2024","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2025.109364_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140153","article-title":"Synthesis, cytotoxic evaluation, and in silico studies of novel benzenesulfonamide-thiazolidinone derivatives against colorectal carcinoma","volume":"1321","author":"Zengin Kurt","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109364_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138998","article-title":"Synthesis of pyrrole-heterocyclic derivatives as anti-Alzheimer and antidiabetic candidates: an in vitro-in silico study","volume":"1315","author":"Petrova","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109364_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117915","article-title":"Synthesis, characterization, in vitro and in silico investigations of novel 1,2,3-triazole substituted salicylic acid phenolic hydrazones hybrids targeting TGF-\u03b22 expression in colorectal carcinoma","volume":"296","author":"Ay","year":"2025","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T20:40:19Z","timestamp":1768423219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825012441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":77,"alternative-id":["S0045206825012441"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109364","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A series of 4-thiomorpholinophenyl-thiosemicarbazones as cholinesterase inhibitors with anti-neuroblastoma effects","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109364"}}